• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Clopidogrel
    4 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Clood
    Unipharm
    RX
    partial basket chart
    Clood

    Antiplatelet Agent. Clopidogrel (as hydrogen sulphate) 75 mg.
    TABS: 30. 75 mg dly as single dose
    with/out food. Non-ST seg. elevat.
    acute coronary syndr. (unstable
    angina/non-Q-wave MI). Initial: 300
    mg load. dose, cont. with 75 mg 1 x dly
    (with ASA 75-325 mg dly - optimal:
    100 mg dly). Max benefit within 3
    mths. but can cont. for up to 12 mths.
    ST seg. elevat. acute MI: 75 mg 1 x dly.
    Load dose (in comb. with ASA with/
    without thrombolyts.): Pts. over 75 yrs:
    Comb. ther. as soon as possible aft.
    onset sympts. Cont. for at least 4 wks.
    Under 18 yrs: Safety/efficacy not
    established.
    Prevent. atherothromb: In pts. with M.I.
    (from a few days until less than 35 days),
    ischem. stroke (from 7 days-6 mths) or
    estab. periph. art. dis. History recent M.I.,
    recent stroke, estab. periph. art. dis, to
    reduce rate of comb. endpoint new
    ischem. stroke (fatal or not), new M.I. (fatal
    or not), and other vasc. death. Acute
    coron. syndr. [non-ST seg. elevat. acute
    coron. syndr. (unstable angina/non-Qwave
    M.I.) or ST seg. elevat. acute M.I. ] in
    comb. with ASA in medically treat. pts.
    eligible for thrombolyt. ther., percutan.
    coron. intervent. (with/out stent) or CABG,
    to decr. rate comb. endpoint CV death,
    M.I., stroke or refract. ischem.

    Clopidexcel 75
    Dexcel
    RX
    partial basket chart
    Clopidexcel 75

    Antiplatelet Agent. Clopidogrel (as Besylate) 75 mg.
    TABS: 30
    75 mg dly as single dose with/without food. Non-ST seg. elevat. acute coronary syndr. (unstab. ang. non-Q-wave MI). Init.: 300 mg load. dose, cont. with 75 mg 1 x dly (with ASA 75-325 mg dly – optimal: 100 mg dly). Max benefit within 3 mths. but can cont. for up to 12 mths. ST seg. elevat. acute MI: 75 mg 1 x dly. Load dose (in comb. with ASA with/without thrombolyts.): Pts. over 75 yrs: Init. without load dose. Comb ther. as soon as possible aft. onset sympts. Cont. for at least 4 wks. Atrial fibrillat.: 75 mg 1 x dly with ASA (75-100 mg dly) Under 18 yrs: not indicated.  

    Second. prevent. atherothromb: In adult. with M.I.(from a few days until less than 35 d.),.ischem. stroke (from 7 days-6 mths) or estab. periph. art. dis.
    Adults with Acute coron. syndr. non-ST seg. elevat. acute coron. syndr. (unstable angina/non-Q-wave M.I.) includ. pts. undergoing stent placement foll. percutan. coron. intervent., in comb. with ASA. ST seg. elevat. acute MI, in comb. with ASA in medically treat. pts. eligible for thrombolyt. ther.
    Prevent. atherothromb/thromboemb. events in atrial fibrillat: Adult. with atrial fibrillat. with at least one risk factor for vasc. events, and not suitable for tmt. with VKA, anti-thrombin or anti factor Xa, who have low bleed. risk. in combinat. with ASA for prevent. atherothrombotic/thromboemb. events, includ. stroke.

    C/I:
    Hypersens., severe hep. impair., active path. bleed. as peptic ulc., intracran. hemorrhage. See lit.

    Clopidogrel Teva
    Teva
    RX
    partial basket chart
    Clopidogrel Teva

    Antiplatelet Agent. Clopidogrel (as bisulfate) 75 mg.
    TABS: 30 x 75 mg. Adults, elderly: 75
    mg 1 x dly, with/out food. Non-ST
    segment elevat., acute coron. syndr.
    (unstable ang./non-Q-wave MI): Load.
    dose: Single 300 mg, foll. by 75 mg 1 x
    dly with ASA 75 mg-325 mg dly. ASA
    not more than 100 mg. Use up to 12
    mths. Max. benefit at 3 mths. ST
    segment elevat., acute MI: Single dly
    dose: 75 mg initiated with load. dose
    in comb. with ASA, with/out
    thrombolytics. 75 years and over:
    Initiate without load. dose. Comb. ther.
    as early as possible aft. sympts. start
    and cont. for at least 4 wks. Safety/
    efficacy below 18 yrs not established.
    No experience in child.
    Prevent. atherothromb: In pts. with M.I.
    (from a few days until less than 35 days),
    ischem. stroke (from 7 days-6 mths) or
    estab. periph. art. dis. History recent M.I.,
    recent stroke, estab. periph. art. dis, to
    reduce rate of comb. endpoint new
    ischem. stroke (fatal or not), new M.I.
    (fatal or not), and other vasc. death.
    Acute coron. syndr. [non-ST seg. elevat.
    acute coron. syndr. (unstable angina/
    non-Q-wave M.I.) or ST seg. elevat. acute
    M.I. ] in comb. with ASA in medically
    treat. pts. eligible for thrombolyt. ther.,
    percutan. coron. intervent. (with/out
    stent) or CABG, to decr. rate comb.
    endpoint CV death, M.I., stroke or refract.
    ischem.
    C/I: Hypersens., severe liver impair.,
    active path. bleed. (pept. ulc./intracran.
    hemorrh.), lact.

    Plavix
    Sanofi
    RX
    partial basket chart
    Plavix

    Antiplatelet Agent. Clopidogrel (as hydrogen sulphate) 75 mg, 300 mg.
    F.C. TABS: 30 x 75 mg; 4, 30, 100 x 300
    mg. 75 mg dly as single dose with/out
    food. Non-ST seg. elevat. acute
    coronary syndr. (unstable angina/non-
    Q-wave MI). Initial: 300 mg load. dose,
    cont. with 75 mg 1 x dly (with ASA
    75-325 mg dly - optimal: 100 mg dly).
    Max benefit within 3 mths. but can
    cont. for up to 12 mths. ST seg. elevat.
    acute MI: 75 mg 1 x dly. Load dose (in
    comb. with ASA with/without
    thrombolyts.): Pts. over 75 yrs: Comb.
    ther. as soon as possible aft. onset
    sympts. Cont. for at least 4 wks. Under
    18 yrs: Safety/ efficacy not established.
    Prevent. atherothromb.: In adults with M.I.
    (from a few days until less than 35 days),
    ischem. stroke (from 7 days-6 mths) or
    estab. periph. art. dis. Adults with acute
    coron. syndr. non-ST seg. elevat. acute
    coron. syndr. (unstable angina/non-Qwave
    M.I.), includ. pts. undergoing stent
    placement foll. percutan. coron. intervent.,
    in comb. with ASA in medically treat. pts.
    eligible for thrombolyt. ther. Prevent.
    atherothromb/thromboemb. events in
    atrial fibrillat: Adults with atrial fibrillat.
    with at least one risk factor for vasc.
    events, and not suitable for tmt. with VKA,
    anti-thrombin or anti factor Xa, who have
    low bleed. risk. in combinat. with ASA for
    prevent.
    atherothrombotic/thromboemb. events,
    includ. stroke.
    C/I: Hypersens., severe hep. impair.,
    active path. bleed. as peptic ulc., intracr.
    haemorrhage.

    CLOSE